Status:

UNKNOWN

The Effect of Reflective Breathing Therapy Compared With Conventional Breathing Therapy in Patients With Chronic Obstructive Pulmonary Disease (COPD) III-IV; part2

Lead Sponsor:

Schön Klinik Berchtesgadener Land

Conditions:

Chronic Obstructive Pulmonary Disease

Eligibility:

All Genders

50-75 years

Phase:

NA

Brief Summary

The purpose of this study is to determine whether different types of breathing therapies in patients with COPD III-IV decrease dyspnea, increase activity and have impact on parasympathetic activities.

Eligibility Criteria

Inclusion

  • inpatient rehabilitation
  • COPD (Gold stage III and IV)

Exclusion

  • severe exacerbation in the last four weeks
  • acute infections
  • fever
  • neuritides
  • severe osteoporosis
  • skin disease
  • manic depression

Key Trial Info

Start Date :

January 1 2016

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

March 1 2020

Estimated Enrollment :

44 Patients enrolled

Trial Details

Trial ID

NCT01905982

Start Date

January 1 2016

End Date

March 1 2020

Last Update

June 18 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Schön Klinik Berchtesgadener Land

Schönau, Bavaria, Germany, 83471

The Effect of Reflective Breathing Therapy Compared With Conventional Breathing Therapy in Patients With Chronic Obstructive Pulmonary Disease (COPD) III-IV; part2 | DecenTrialz